重新审视腹腔细胞学:探索其在子宫内膜癌分子分型中的作用
该研究纳入2004至2015年在瑞士伯尔尼大学医院接受初次手术治疗的子宫内膜癌患者,分析腹腔细胞学阳性在不同分子亚组中的预后意义。206例接受细胞学评估的患者中24%为阳性,阳性与p53abn和NSMP亚组无复发生存及总生存显著下降相关;在多变量分析中,阳性腹腔细胞学是p53abn患者复发和死亡的独立预测因素。
要点
- 腹腔细胞学阳性率在p53abn亚组为41%,POLEmut为25%,NSMP为24%,MMRd为16%。
- 腹腔细胞学阳性与p53abn和NSMP患者无复发生存及总生存显著下降相关。
- 在p53abn子宫内膜癌中,腹腔细胞学阳性是复发和死亡的独立预测因素。
核心结论
- 腹腔细胞学阳性与NSMP和p53abn子宫内膜癌患者较差的肿瘤学结局相关,并且在p53abn子宫内膜癌患者中仍是复发和死亡的独立预测因素。
研究设计与样本
- 该研究纳入2004年至2015年在瑞士伯尔尼大学医院接受初次手术治疗的子宫内膜癌患者,要求对原发肿瘤进行分子分型并实施腹腔细胞学检查。
- 共纳入250例子宫内膜癌患者,其中206例接受了腹腔细胞学评估。
主要发现
- 206例接受腹腔细胞学评估的患者中24%为阳性;阳性率在POLEmut为25%,MMRd为16%,p53abn为41%,NSMP为24%。
- 中位随访时间为128.7个月。
- 腹腔细胞学阳性与p53abn患者无复发生存(p = .003)和总生存(p = .001)显著下降相关,也与NSMP患者无复发生存(p = .020)和总生存(p = .049)显著下降相关。
- 在多变量Cox回归分析中,腹腔细胞学阳性仍是p53abn子宫内膜癌患者复发的独立预测因素(p = .033)和死亡的独立预测因素(p = .008)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The prognostic significance of positive peritoneal cytology in endometrial cancer has long been debated. In 2009, the Fédération Internationale de Gynécologie et d'Obstétrique (FIGO) removed cytology as a staging criterion from the endometrial cancer staging system. However, there is still evidence that positive peritoneal cytology may decrease survival among patients with endometrial cancer. The aim of this study was to determine the prognostic significance of positive peritoneal cytology among the different molecular subgroups. METHODS: This study included patients with endometrial cancer who underwent primary surgical treatment between 2004 and 2015 at the Bern University Hospital, Switzerland, with molecular classification of the primary tumor and peritoneal cytology performed. RESULTS: A total, 250 patients with endometrial cancer were enrolled. Peritoneal cytology was assessed in 206 patients, of whom 24% were positive: 25% of the POLEmut, 16% of the MMRd, 41% of the p53abn, and 24% of the NSMP cases. The mean follow-up was 128.7 months. Presence of positive peritoneal cytology was associated with significantly decreased mean recurrence-free and overall survival in patients with p53abn (p = .003 and p = .001) and NSMP (p = .020 and p = .049) endometrial cancer. In multivariable Cox regression analysis, positive peritoneal cytology remained an independent predictor of recurrence (p = .033) and death (p = .008) in p53abn endometrial cancer patients. CONCLUSION: Positive peritoneal cytology is associated with worse oncologic outcomes in NSMP and p53abn endometrial cancer and remains an independent predictor of recurrence and death in patients with p53abn endometrial cancer.
引用
- Villiger AS, Zurbriggen S, Imboden S, et al. Reviving peritoneal cytology: Exploring its role in endometrial cancer molecular classification. Gynecol Oncol. 2024. PMID: 38266401. doi:10.1016/j.ygyno.2024.01.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。